Literature DB >> 32441414

Relationship Between Pain, Opioid Treatment, and Delirium in Older Emergency Department Patients.

Raoul Daoust1,2, Jean Paquet2, Valérie Boucher3,4, Mathieu Pelletier5,6, Émilie Gouin7, Marcel Émond3,4,5.   

Abstract

OBJECTIVES: Emergency department (ED) stay and its associated conditions (immobility, inadequate hydration and nutrition, lack of stimulation) increase the risk of delirium in older patients. Poorly controlled pain and paradoxically opioid pain treatment have also been identified as triggers for delirium. The aim of this study was to assess the relationship between pain, opioid treatment, and delirium in older ED patients.
METHODS: A multicenter prospective cohort study was conducted in four hospitals across the province of Québec (Canada). Patients aged ≥ 65 years old, waiting for hospital admission between March and July 2015, who were nondelirious upon ED arrival, who were independent or semi-independent in their daily living activities, and who had an ED stay of at least 8 hours were included. Delirium assessments were conducted twice a day during the patient's entire ED stay and their first 24 hours on the hospital ward using the Confusion Assessment Method. Pain intensity was evaluated using a visual analog scale (VAS = 0-100) during the initial interview, and all opioid treatments were documented.
RESULTS: A total of 338 patients were included; 51% were female, and mean (±SD) age was 77 (±8) years. Forty-one patients (12%) experienced delirium during their hospital stay occurring within a mean (±SD) delay of 47 (±19) hours after ED admission. Among patients with pain intensity ≥ 65 from VAS (0-100), 26% experienced delirium compared to 11% for patients with pain < 65 (p < 0.01), and no significant association was found between opioid consumption and delirium (p = 0.31). Logistic regression controlling for confounding factors showed that patients with pain intensity ≥ 65 are 3.3 (95% confidence interval = 1.4 to 7.9) times more likely to develop delirium than patients who had pain intensity of <65.
CONCLUSIONS: Severe pain, not opioids, is associated with the development of delirium during ED stay. Adequate pain control during the hospital stay may contribute to a decrease in delirium episodes.
© 2020 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32441414     DOI: 10.1111/acem.14033

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  5 in total

1.  Hospitalizations of older people in an emergency department related to potential medication-induced hyperactive delirium: a cross-sectional study.

Authors:  Júlia Raso; Lincoln Marques Cavalcante Santos; Débora Alves Reis; Marília Amaral Costa Frangiotti; Ariane Cristina Barboza Zanetti; Helaine Carneiro Capucho; Maria Teresa Herdeiro; Fátima Roque; Leonardo Régis Leira Pereira; Fabiana Rossi Varallo
Journal:  Int J Clin Pharm       Date:  2022-01-27

2.  Pain management in emergency department older adults with pelvic fracture: still insufficient.

Authors:  Axel Benhamed; Valérie Boucher; Marcel Emond
Journal:  CJEM       Date:  2022-04-11       Impact factor: 2.410

3.  Opioid and benzodiazepine use in the emergency department and the recognition of delirium within the first 24 hours of hospitalization.

Authors:  Sangil Lee; Uche Eseoghene Okoro; Morgan Bobb Swanson; Nicholas Mohr; Brett Faine; Ryan Carnahan
Journal:  J Psychosom Res       Date:  2021-12-16       Impact factor: 4.620

4.  Incidence of Dissociation With Low-Dose Pre-hospital Ketamine in Geriatric Patients With Trauma-Related Pain.

Authors:  Melanie M Randall; Jennifer Raae-Nielsen; Mia Choi; William S Dukes; Timothy Nesper; Michael K Mesisca
Journal:  Cureus       Date:  2022-08-05

Review 5.  Can we improve delirium prevention and treatment in the emergency department? A systematic review.

Authors:  Sangil Lee; Hao Chen; Seikei Hibino; Daniel Miller; Heather Healy; Jacques S Lee; Glenn Arendts; Jin Ho Han; Maura Kennedy; Christopher R Carpenter
Journal:  J Am Geriatr Soc       Date:  2022-03-11       Impact factor: 7.538

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.